These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3203427)

  • 1. Bayesian prediction of serum phenytoin concentration in a simulation study.
    Higuchi S; Yukawa E; Aoyama T
    Chem Pharm Bull (Tokyo); 1988 May; 36(5):1914-8. PubMed ID: 3203427
    [No Abstract]   [Full Text] [Related]  

  • 2. Bayesian regression analysis of non-steady-state phenytoin concentrations: evaluation of predictive performance.
    Killilea T; Coleman R; Ludden T; Peck CC; Rose D
    Ther Drug Monit; 1989; 11(4):455-62. PubMed ID: 2741195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An updated comparison of drug dosing methods. Part I: Phenytoin.
    Pryka RD; Rodvold KA; Erdman SM
    Clin Pharmacokinet; 1991 Mar; 20(3):209-17. PubMed ID: 1902764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosage of phenytoin in neurocritical patients using Bayesian algorithms: a pilot study.
    Muñoz-Pichuante D; Villa Zapata L; Cabrera S; Lagos X; Grandjean J
    Drug Metab Pers Ther; 2019 Dec; 34(4):. PubMed ID: 31981450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for prediction of phenytoin levels in the acute clinical setting.
    Scheyer RD; Mattson RH
    Comput Biomed Res; 1991 Dec; 24(6):564-75. PubMed ID: 1769232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a Bayesian forecasting technique with a new method for estimating phenytoin dose requirements.
    Bryson SM; Al-Lanqawi Y; Kelman AW; Whiting B
    Ther Drug Monit; 1988; 10(1):80-4. PubMed ID: 3376186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of graphical nomogram methods with a computerized Bayesian analysis method in the interpretation of serum phenytoin concentrations.
    Chrystyn H; Morgan DH
    J Clin Hosp Pharm; 1986 Dec; 11(6):443-8. PubMed ID: 3818966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-Dependent Decline in Serum Phenytoin Concentration With Heightened Convulsive Seizure Risk by Prolonged Administration of Fosphenytoin in Japanese: A Retrospective Study.
    Ohno Y; Niwa T; Hirai K; Suzuki K; Yamada Y; Hayashi Y; Hayashi H; Suzuki A; Itoh Y
    Ther Drug Monit; 2018 Aug; 40(4):507-511. PubMed ID: 29683874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a bayesian pharmacokinetic program for phenytoin concentration predictions in outpatient population.
    Gaulier JM; Boulieu R; Fischer C; Mauguiere
    Eur J Drug Metab Pharmacokinet; 1998; 23(2):295-300. PubMed ID: 9725496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of the convenient and direct numerical analytical method of the pharmacokinetics of phenytoin by an ordinary and/or the Bayesian weighted least-squares method using the program MULTI2(BAYES).
    Fujita T; Koshiro A
    J Pharmacobiodyn; 1989 Dec; 12(12):717-25. PubMed ID: 2635729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a Bayesian regression-analysis computer program for predicting phenytoin concentration.
    Ludden TM; Beal SL; Peck CC; Godley PJ
    Clin Pharm; 1986 Jul; 5(7):580-5. PubMed ID: 3755661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a Bayesian regression-analysis computer program using non-steady-state phenytoin concentrations.
    Godley PJ; Ludden TM; Clementi WA; Godley SE; Ramsey RR
    Clin Pharm; 1987 Aug; 6(8):634-9. PubMed ID: 3691009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of population pharmacokinetic parameters in phenytoin dosage adjustment.
    Yukawa E; Higuchi S; Aoyama T
    Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3363-6. PubMed ID: 2632085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing a mass-balance algorithm with a Bayesian regression analysis computer program for predicting serum phenytoin concentrations.
    Choy M; Winter ME
    Am J Health Syst Pharm; 1998 Nov; 55(22):2392-6. PubMed ID: 9825035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin clearances in a compliant population: description and application.
    Graves NM; Leppik IE; Termond E; Taylor JW
    Ther Drug Monit; 1986; 8(4):427-33. PubMed ID: 3824428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian graphic method for predicting individual phenytoin dosage schedule.
    Cai WM; Chu XM; Chen G
    Zhongguo Yao Li Xue Bao; 1991 Mar; 12(2):141-4. PubMed ID: 1776478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin dosage predictions in paediatric patients.
    Yuen GJ; Latimer PT; Littlefield LC; Mackey RW
    Clin Pharmacokinet; 1989 Apr; 16(4):254-60. PubMed ID: 2721089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy.
    Odani A; Hashimoto Y; Otsuki Y; Uwai Y; Hattori H; Furusho K; Inui K
    Clin Pharmacol Ther; 1997 Sep; 62(3):287-92. PubMed ID: 9333104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamazepine increases phenytoin serum concentration and reduces phenytoin clearance.
    Browne TR; Szabo GK; Evans JE; Evans BA; Greenblatt DJ; Mikati MA
    Neurology; 1988 Jul; 38(7):1146-50. PubMed ID: 3386835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenobarbital does not alter phenytoin steady-state serum concentration or pharmacokinetics.
    Browne TR; Szabo GK; Evans J; Evans BA; Greenblatt DJ; Mikati MA
    Neurology; 1988 Apr; 38(4):639-42. PubMed ID: 3352926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.